The NAD+ salvage pathway modulates cancer cell viability via p73

Cell Death and Differentiation

Volumn 23, Issue 4, 2016, Pages 669-680

  Sharif, T ^a   Ahn, D G ^a   Liu, R Z ^b   Pringle, E ^a   Martell, E ^a   Dai, C ^a   Nunokawa, A ^a   Kwak, M ^a   Clements, D ^a   Murphy, J P ^a   Dean, C ^a   Marcato, P ^a   McCormick, C ^a   Godbout, R ^b   Gujar, S A ^a,c   Lee, P W K ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c IWK HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DAPORINAD; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE NUCLEOTIDE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PROTEIN P53; PROTEIN P73; CYTOKINE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE, HUMAN; P73 PROTEIN, HUMAN; TP53 PROTEIN, HUMAN; TUMOR PROTEIN P73;

ACETYLATION; ARTICLE; AUTOPHAGY; BREAST CANCER; BREAST CANCER CELL LINE; CANCER DIAGNOSIS; CANCER GRADING; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CANCER THERAPY; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENZYME INHIBITION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; MCF 10A CELL LINE; MCF 7 CELL LINE; MDA MB 231 CELL LINE; MDA MB 468 CELL LINE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN STABILITY; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; UBIQUITINATION; GENETICS; JURKAT CELL LINE; MCF-7 CELL LINE; METABOLISM; MORTALITY; NEOPLASM; PATHOLOGY;

AUTOPHAGY; CELL SURVIVAL; CYTOKINES; HUMANS; JURKAT CELLS; MCF-7 CELLS; NAD; NEOPLASMS; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; TUMOR PROTEIN P73; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84960849046     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2015.134     Document Type: Article

References (39)

1. Guo XE, Ngo B, Modrek AS, Lee WH. Targeting tumor suppressor networks for cancer therapeutics. Curr Drug Targets 2014; 15: 2-16.
2. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000; 408: 307-310.
3. Agarwal ML, Taylor WR, Chernov MV, Chernova OB, Stark GR. The p53 network. J Biol Chem 1998; 273: 1-4.
4. Hussain SP, Harris CC. P53 mutation spectrum and load: the generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer. Mutat Res 1999; 428: 23-32.
5. Sidransky D, Tokino T, Helzlsouer K, Zehnbauer B, Rausch G, Shelton B et al. Inherited p53 gene mutations in breast cancer. Cancer Res 1992; 52: 2984-2986.
6. Slade N, Horvat A. Targeting p73-a potential approach in cancer treatment. Curr Pharm Des 2011; 17: 591-602.
7. Vilgelm A, El-Rifai W, Zaika A. Therapeutic prospects for p73 and p63: rising from the shadow of p53. Drug Resist Updat 2008; 11: 152-163.
8. Amin AR, Paul RK, Thakur VS, Agarwal ML. A novel role for p73 in the regulation of Akt-Foxo1a-Bim signaling and apoptosis induced by the plant lectin, concanavalin A. Cancer Res 2007; 67: 5617-5621.
9. Amin AR, Thakur VS, Paul RK, Feng GS, Qu CK, Mukhtar H et al. SHP-2 tyrosine phosphatase inhibits p73-dependent apoptosis and expression of a subset of p53 target genes induced by EGCG. Proc Natl Acad Sci USA 2007; 104: 5419-5424.
10. Kyrylenko S, Baniahmad A. Sirtuin family: a link to metabolic signaling and senescence. Curr Med Chem 2010; 17: 2921-2932.
11. Fan QD, Wu G, Liu ZR. Dynamics of posttranslational modifications of p53. Comput Math Methods Med 2014; 2014: 245610.
12. Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, Pandita TK et al. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 2001; 107: 149-159.
13. Oberdoerffer P, Michan S, McVay M, Mostoslavsky R, Vann J, Park SK et al. SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging. Cell 2008; 135: 907-918.
14. Ternes CM, Schonknecht G. Gene transfers shaped the evolution of de novo NAD+ biosynthesis in eukaryotes. Genome Biol Evol 2014; 6: 2335-2349.
15. Verdin E. The many faces of sirtuins: coupling of NAD metabolism, sirtuins and lifespan. Nat Med 2014; 20: 25-27.
16. Pan LZ, Ahn DG, Sharif T, Clements D, Gujar SA, Lee PW. The NAD+ synthesizing enzyme nicotinamide mononucleotide adenylyltransferase 2 (NMNAT-2) is a p53 downstream target. Cell Cycle 2014; 13: 1041-1048.
17. Ngo H, Tortorella SM, Ververis K, Karagiannis TC. The Warburg effect: molecular aspects and therapeutic possibilities. Mol Biol Rep 2014; 42: 825-834.
18. Dong WR, Xiang LX, Shao JZ. Novel antibiotic-free plasmid selection system based on complementation of host auxotrophy in the NAD de novo synthesis pathway. Appl Environ Microbiol 2010; 76: 2295-2303.
19. Billington RA, Genazzani AA, Travelli C, Condorelli F. NAD depletion by FK866 induces autophagy. Autophagy 2008; 4: 385-387.
20. Cea M, Cagnetta A, Fulciniti M, Tai YT, Hideshima T, Chauhan D et al. Targeting NAD+ salvage pathway induces autophagy in multiple myeloma cells via mTORC1 and extracellular signal-regulated kinase (ERK1/2) inhibition. Blood 2012; 120: 3519-3529.
21. Cagnetta A, Cea M, Calimeri T, Acharya C, Fulciniti M, Tai YT et al. Intracellular NAD(+) depletion enhances bortezomib-induced anti-myeloma activity. Blood 2013; 122: 1243-1255.
22. Schuster S, Penke M, Gorski T, Gebhardt R, Weiss TS, Kiess W et al. FK866-induced NAMPT inhibition activates AMPK and downregulates mTOR signaling in hepatocarcinoma cells. Biochem Biophys Res Commun 2015; 458: 334-340.
23. Luo J, Li M, Tang Y, Laszkowska M, Roeder RG, Gu W. Acetylation of p53 augments its sitespecific DNA binding both in vitro and in vivo. Proc Natl Acad Sci USA 2004; 101: 2259-2264.
24. Simbulan-Rosenthal CM, Rosenthal DS, Luo RB, Samara R, Jung M, Dritschilo A et al. Poly (ADP-ribosyl)ation of p53 in vitro and in vivo modulates binding to its DNA consensus sequence. Neoplasia 2001; 3: 179-188.
25. He Z, Liu H, Agostini M, Yousefi S, Perren A, Tschan MP et al. p73 regulates autophagy and hepatocellular lipid metabolism through a transcriptional activation of the ATG5 gene. Cell Death Differ 2013; 20: 1415-1424.
26. Matsumura N, Tanuma S. Involvement of cytosolic NAD+ glycohydrolase in cyclic ADP-ribose metabolism. Biochem Biophys Res Commun 1998; 253: 246-252.
27. Lee IH, Cao L, Mostoslavsky R, Lombard DB, Liu J, Bruns NE et al. A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proc Natl Acad Sci USA 2008; 105: 3374-3379.
28. Wang J, He Z. NAD and axon degeneration: from the Wlds gene to neurochemistry. Cell Adhes Migr 2009; 3: 77-87.
29. Prolla TA, Denu JM. NAD+ deficiency in age-related mitochondrial dysfunction. Cell Metab 2014; 19: 178-180.
30. Muller-Steffner H, Augustin A, Schuber F. Involvement of bovine spleen NAD+ glycohydrolase in the metabolism of cyclic ADP-ribose-mechanism of the cyclization reaction. Adv Exp Med Biol 1997; 419: 399-409.
31. Bi TQ, Che XM. Nampt/PBEF/visfatin and cancer. Cancer Biol Ther 2010; 10: 119-125.
32. Jieyu H, Chao T, Mengjun L, Shalong W, Xiaomei G, Jianfeng L et al. Nampt/Visfatin/PBEF: a functionally multi-faceted protein with a pivotal role in malignant tumors. Curr Pharm Des 2012; 18: 6123-6132.
33. Gehrke I, Bouchard ED, Beiggi S, Poeppl AG, Johnston JB, Gibson SB et al. On-target effect of FK866, a nicotinamide phosphoribosyl transferase inhibitor, by apoptosismediated death in chronic lymphocytic leukemia cells. Clin Cancer Res 2014; 20: 4861-4872.
34. Liu Y, Shoji-Kawata S, Sumpter RM Jr, Wei Y, Ginet V, Zhang L et al. Autosis is a Na+,K+-ATPase-regulated form of cell death triggered by autophagy-inducing peptides, starvation, and hypoxia-ischemia. Proc Natl Acad Sci USA 2013; 110: 20364-20371.
35. Gilley J, Coleman MP. Endogenous Nmnat2 is an essential survival factor for maintenance of healthy axons. PLoS Biol 2010; 8: e1000300.
36. Wen Y, Parrish JZ, He R, Zhai RG, Kim MD. Nmnat exerts neuroprotective effects in dendrites and axons. Mol Cell Neurosci 2011; 48: 1-8.
37. Talos F, Abraham A, Vaseva AV, Holembowski L, Tsirka SE, Scheel A et al. p73 is an essential regulator of neural stem cell maintenance in embryonal and adult CNS neurogenesis. Cell Death Differ 2010; 17: 1816-1829.
38. Wetzel MK, Naska S, Laliberte CL, Rymar VV, Fujitani M, Biernaskie JA et al. p73 regulates neurodegeneration and phospho-tau accumulation during aging and Alzheimer's disease. Neuron 2008; 59: 708-721.
39. Marcato P, Dean CA, Liu RZ, Coyle KM, Bydoun M, Wallace M et al. Aldehyde dehydrogenase 1A3 influences breast cancer progression via differential retinoic acid signaling. Mol Oncol 2015; 9: 17-31.